ARTICLE | Company News
NPS, Janssen Pharmaceutica NV deal
November 12, 2001 8:00 AM UTC
NPSP received a milestone from Janssen triggered by Janssen’s selection of a preclinical small molecule inhibitor of glycine for further development as a treatment for schizophrenia. The 1998 agreemen...